ArticleScientific reports2026
An intelligent drug supply chain management and recommendation framework using blockchain and TRPO-driven multi-agent learning.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pharmaceutical companies increasingly face difficulties in tracking products across the supply chain, enabling counterfeiters to introduce fake medicines that cause substantial economic losses and serious health risks. A mechanism capable of tracing and monitoring drug movement at every stage is therefore essential. Blockchain offers a promising foundation for secure and transparent supply chain tracking. This paper introduces a two-module framework. It integrates a blockchain-based drug supply chain management (DSCM) system with a multi-agent recommendation model driven by trust region policy optimization (TRPO). The first module employs a customized blockchain to continuously record, monitor, and verify drug movement within a simulated smart pharmaceutical environment. The second module is a sentiment analysis (SA) that operates with two TRPO agents in a blockchain-secured setting. To enhance policy performance, the TRPO agents incorporate entropy regularization. This setup specifically addresses key SA challenges, including handling unlabeled data, feature selection, and class imbalance mitigation. The first agent applies semi-supervised learning (SSL) with pseudo-labels on high-confidence unlabeled samples to expand the training set. The second agent performs SA, applies Shapley additive explanations (SHAP) for feature ranking, and uses reward mechanisms to improve performance on underrepresented classes. The framework was evaluated on two large real-world drug review datasets, Drugs.com and Druglib.com. For Drugs.com, the blockchain module achieved 3.015-second latency and 172.322 tps throughput, while the SA model reached 93.250% accuracy and 94.329% F-measure. For Druglib.com, latency was 2.930 s, throughput was 189.538 tps, accuracy was 95.192%, and F-measure was 96.257%. These results demonstrate the effectiveness of the framework in analyzing patient reviews. It successfully provides secure supply chain recording and sentiment-based insights within controlled experimental conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.